Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib in advanced biliary tract cancer
NCT00939848Phase 3Completed
- Sponsor
- University College London
- Start
- Apr 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cediranib in biliary tract cancer (BTC), sponsored by University College London. Started Apr 2011; status: completed.
02
Drugs
cediranib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00939848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939848.